» Articles » PMID: 34703975

Real-World Evidence for a Smartwatch-Based Parkinson's Motor Assessment App for Patients Undergoing Therapy Changes

Overview
Journal Digit Biomark
Date 2021 Oct 27
PMID 34703975
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Parkinson's disease (PD) is poorly quantified by patients outside the clinic, and paper diaries have problems with subjective descriptions and bias. Wearable sensor platforms; however, can accurately quantify symptoms such as tremor, dyskinesia, and bradykinesia. Commercially available smartwatches are equipped with accelerometers and gyroscopes that can measure motion for objective evaluation. We sought to evaluate the clinical utility of a prescription smartwatch-based monitoring system for PD utilizing periodic task-based motor assessment.

Methods: Sixteen patients with PD used a smartphone- and smartwatch-based monitoring system to objectively assess motor symptoms for 1 week prior to instituting a doctor recommended change in therapy and for 4 weeks after the change. After 5 weeks the participants returned to the clinic to discuss their results with their doctor, who made therapy recommendations based on the reports and his clinical judgment. Symptom scores were synchronized with the medication diary and the temporal effects of therapy on weekly and hourly timescales were calculated.

Results: Thirteen participants successfully completed the study and averaged 4.9 assessments per day for 3 days per week during the study. The doctor instructed 8 participants to continue their new regimens and 5 to revert to their previous regimens. The smartwatch-based assessments successfully captured intraday fluctuations and short- and long-term responses to therapies, including detecting significant improvements ( < 0.05) in at least one symptom in 7 participants.

Conclusions: The smartwatch-based app successfully captured temporal trends in symptom scores following application of new therapy on hourly, daily, and weekly timescales. These results suggest that validated smartwatch-based PD monitoring can provide clinically relevant information and may reduce the need for traditional office visits for therapy adjustment.

Citing Articles

Movement Disorders and Smart Wrist Devices: A Comprehensive Study.

Caroppo A, Manni A, Rescio G, Carluccio A, Siciliano P, Leone A Sensors (Basel). 2025; 25(1.

PMID: 39797057 PMC: 11723440. DOI: 10.3390/s25010266.


Assessing the clinical utility of inertial sensors for home monitoring in Parkinson's disease: a comprehensive review.

Sapienza S, Tsurkalenko O, Giraitis M, Castro Mejia A, Zelimkhanov G, Schwaninger I NPJ Parkinsons Dis. 2024; 10(1):161.

PMID: 39164257 PMC: 11335938. DOI: 10.1038/s41531-024-00755-6.


Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis.

Cox E, Wade R, Hodgson R, Fulbright H, Phung T, Meader N Health Technol Assess. 2024; 28(30):1-187.

PMID: 39021200 PMC: 11331379. DOI: 10.3310/YDSL3294.


Upper limb intention tremor assessment: opportunities and challenges in wearable technology.

Paredes-Acuna N, Utpadel-Fischler D, Ding K, Thakor N, Cheng G J Neuroeng Rehabil. 2024; 21(1):8.

PMID: 38218890 PMC: 10787996. DOI: 10.1186/s12984-023-01302-9.


Home-based monitoring of persons with advanced Parkinson's disease using smartwatch-smartphone technology.

Fay-Karmon T, Galor N, Heimler B, Zilka A, Bartsch R, Plotnik M Sci Rep. 2024; 14(1):9.

PMID: 38167434 PMC: 10761812. DOI: 10.1038/s41598-023-48209-y.


References
1.
Hauser R, FRIEDLANDER J, Zesiewicz T, Adler C, Seeberger L, OBRIEN C . A home diary to assess functional status in patients with Parkinson's disease with motor fluctuations and dyskinesia. Clin Neuropharmacol. 2000; 23(2):75-81. DOI: 10.1097/00002826-200003000-00003. View

2.
Tang P, Newcomb C, Gorden S, Kreider N . Meeting the information needs of patients: results from a patient focus group. Proc AMIA Annu Fall Symp. 1997; :672-6. PMC: 2233596. View

3.
Isaacson S, Boroojerdi B, Waln O, McGraw M, Kreitzman D, Klos K . Effect of using a wearable device on clinical decision-making and motor symptoms in patients with Parkinson's disease starting transdermal rotigotine patch: A pilot study. Parkinsonism Relat Disord. 2019; 64:132-137. DOI: 10.1016/j.parkreldis.2019.01.025. View

4.
Muller T, Voss B, Hellwig K, Przuntek H . Treatment benefit correlates with increase of daily drug costs in Parkinson's disease clinics. NeuroRehabilitation. 2003; 18(3):271-5. View

5.
Goetz C, Tilley B, Shaftman S, Stebbins G, Fahn S, Martinez-Martin P . Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008; 23(15):2129-70. DOI: 10.1002/mds.22340. View